no script no facebook ... not the end of the world.
Chart for article 'Abraxane Expected to Strengthen Celgene's Oncology in 3Q15'
Is this chart helpful to you?
Publisher logo for Yahoo Yahoo 2015

Abraxane Expected to Strengthen Celgene's Oncology in 3Q15

SOURCE ARTICLE:
Abraxane Expected to Strengthen Celgene's Oncology in 3Q15

Abraxane is currently used by ~50% of the pancreatic cancer patients on therapy in the US. The drug is also approved for non-small-cell lung cancer patients.

Related Charts